EP2403497A4 - Verbindungen, zusammensetzungen und verwendung für antikrebstherapie - Google Patents
Verbindungen, zusammensetzungen und verwendung für antikrebstherapieInfo
- Publication number
- EP2403497A4 EP2403497A4 EP10748321.6A EP10748321A EP2403497A4 EP 2403497 A4 EP2403497 A4 EP 2403497A4 EP 10748321 A EP10748321 A EP 10748321A EP 2403497 A4 EP2403497 A4 EP 2403497A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- compositions
- compounds
- anticancer therapy
- anticancer
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15650709P | 2009-03-01 | 2009-03-01 | |
PCT/CN2010/070813 WO2010099731A1 (en) | 2009-03-01 | 2010-03-01 | Compounds, compositions and use for anticancer therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2403497A1 EP2403497A1 (de) | 2012-01-11 |
EP2403497A4 true EP2403497A4 (de) | 2014-01-22 |
Family
ID=42709220
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10748321.6A Withdrawn EP2403497A4 (de) | 2009-03-01 | 2010-03-01 | Verbindungen, zusammensetzungen und verwendung für antikrebstherapie |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2403497A4 (de) |
CN (1) | CN102438620A (de) |
AU (1) | AU2010220755B2 (de) |
WO (1) | WO2010099731A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3045169B1 (de) | 2013-09-13 | 2018-05-02 | Akiko Itai | Rezeptur für eine wässrige lösung und herstellungsverfahren dafür |
KR102436172B1 (ko) * | 2016-03-07 | 2022-08-24 | 미토콘 파마슈티칼스, 인크. | 신경근 질환, 신경 퇴행성 질환, 자가면역 질환, 발달 질환, 진탕, 안구 건조증, 및/또는 대사 질환의 dnp 및 dnp 프로드럭 치료 |
CN108752477A (zh) * | 2018-06-19 | 2018-11-06 | 上海赛群生物科技有限公司 | tNOX抗体及其组合物在制备肿瘤细胞药物中的应用 |
CN110115712A (zh) * | 2019-07-04 | 2019-08-13 | 兰州大学 | 一种同时激活氧化磷酸化通路和抑制糖酵解途径的激活剂及其应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040132004A1 (en) * | 2003-01-06 | 2004-07-08 | Jun Nakamura | Method of detecting DNA single strand breaks |
US20060189680A1 (en) * | 2005-01-31 | 2006-08-24 | Bing-Hua Jiang | Apigenin for chemoprevention, and chemotherapy combined with therapeutic reagents |
WO2009006555A2 (en) * | 2007-07-02 | 2009-01-08 | Yu, Ming | Methods, composition, targets for combinational cancer treatments |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070212360A1 (en) * | 2006-01-17 | 2007-09-13 | Denko Nicholas C | Modulation of mitochondrial oxygen consumption for therapeutic purposes |
-
2010
- 2010-03-01 WO PCT/CN2010/070813 patent/WO2010099731A1/en active Application Filing
- 2010-03-01 AU AU2010220755A patent/AU2010220755B2/en not_active Ceased
- 2010-03-01 CN CN2010800187658A patent/CN102438620A/zh active Pending
- 2010-03-01 EP EP10748321.6A patent/EP2403497A4/de not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040132004A1 (en) * | 2003-01-06 | 2004-07-08 | Jun Nakamura | Method of detecting DNA single strand breaks |
US20060189680A1 (en) * | 2005-01-31 | 2006-08-24 | Bing-Hua Jiang | Apigenin for chemoprevention, and chemotherapy combined with therapeutic reagents |
WO2009006555A2 (en) * | 2007-07-02 | 2009-01-08 | Yu, Ming | Methods, composition, targets for combinational cancer treatments |
Non-Patent Citations (1)
Title |
---|
See also references of WO2010099731A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP2403497A1 (de) | 2012-01-11 |
AU2010220755A1 (en) | 2011-10-27 |
CN102438620A (zh) | 2012-05-02 |
WO2010099731A1 (en) | 2010-09-10 |
AU2010220755B2 (en) | 2013-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL242999B (en) | Pyrazolopyrimidine compounds, pharmaceutical preparations containing them and their uses | |
ZA201200054B (en) | Therapeutic compounds and compositions | |
HK1253355A1 (zh) | 含有馬西替坦的治療組合物 | |
GB0909680D0 (en) | Dosage form | |
AP3250A (en) | Tablets for combination therapy | |
IL216388A0 (en) | New compounds, pharmaceutical composition and methods relating thereto | |
GB0808835D0 (en) | Therapeutic compositions | |
GB0819958D0 (en) | Therapeutic compositions | |
EP2485721A4 (de) | Apogossypolonderivate als antikrebsmittel | |
EP2565192A4 (de) | Krebsmittel | |
IL212375A0 (en) | Naphthamides as anticancer agents | |
EP2544542A4 (de) | Schmerzmittelverbindungen, zusammensetzungen daraus und ihre verwendung | |
EP2403497A4 (de) | Verbindungen, zusammensetzungen und verwendung für antikrebstherapie | |
IL208001A0 (en) | Improved anticancer treatments | |
GB0915319D0 (en) | Combination medicament | |
IL213445A0 (en) | Anticancer compounds | |
PL2263454T3 (pl) | Kompozycja uzdatniająca | |
GB0916997D0 (en) | Combination therapy | |
GB0900786D0 (en) | Therapeutic compositions | |
EP2490704A4 (de) | Therapeutische zusammensetzung | |
GB0907973D0 (en) | Combination therapy | |
GB201010608D0 (en) | Compounds, compositions and use | |
GB0908537D0 (en) | Compositions for treating tumours | |
EP2474325A4 (de) | Arzneimittelzusammensetzung zur angiogenesetherapie | |
GB0814469D0 (en) | Treatment for tumours |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20110923 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20140107 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 45/06 20060101ALI20131219BHEP Ipc: A61K 31/41 20060101AFI20131219BHEP Ipc: A61K 31/498 20060101ALI20131219BHEP Ipc: A61P 35/00 20060101ALI20131219BHEP Ipc: A61K 31/352 20060101ALI20131219BHEP Ipc: A61K 31/353 20060101ALI20131219BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20140805 |